ResearcherBroad InstituteActive in the last 2 years
Brendan D. Parent
Matched on ORCID iD 0009-0001-8258-1755; OpenAlex author ID A5006837949. Sources: OpenAlex.
Their work
- Papers
- 4
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 23
2024: 1 paper · 2025: none · 2026: 3 papers
Papers 4
- CD4 T cells convert transient responses to KRAS inhibition to durable remissions in pancreatic cancer. Co-author DOI 10.1016/j.cell.2026.08.045↗
- Growth factor supportive care for chemotherapy-induced neutropenia suppresses antitumour immunity in checkpoint blockade-responsive pancreatic cancer. Co-author DOI 10.1093/immadv/ltag013↗
- KRAS inhibition drives adaptive surfaceome remodeling and reveals ALPP/ALPPL2 as a targetable vulnerability in pancreatic cancer Co-author DOI 10.64898/2026.10.01.756025↗
- Mechanisms of Resistance to Oncogenic KRAS Inhibition in Pancreatic Cancer. Co-author DOI 10.1158/2159-8290.cd-24-0177↗
Closest collaborators
The 23 strongest of 23 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Andrew J. Aguirre · 3 shared papers, 2026 · strength 0.75
- Paper Growth factor supportive care for chemotherapy-induced neutropenia suppresses antitumour immunity in checkpoint blockad… DOI 10.1093/immadv/ltag013↗
- Paper KRAS inhibition drives adaptive surfaceome remodeling and reveals ALPP/ALPPL2 as a targetable vulnerability in pancreat… DOI 10.64898/2026.10.01.756025↗
- Paper CD4 T cells convert transient responses to KRAS inhibition to durable remissions in pancreatic cancer. DOI 10.1016/j.cell.2026.08.045↗
- Michael Lawrence Dougan · 2 shared papers, 2026 · strength 0.54
- Megan T. Hoffman · 2 shared papers, 2026 · strength 0.54
- Stephanie K. Dougan · 2 shared papers, 2026 · strength 0.54
- Joseph Douglas Mancias · 2 shared papers, 2026 · strength 0.39
- Jonathan M. DeLiberty · 1 shared paper, 2026 · strength 0.21
- Timothy Paul Heffernan · 1 shared paper, 2026 · strength 0.21
- Joao A Paulo · 1 shared paper, 2026 · strength 0.21
- Tobiloba E. Oni · 1 shared paper, 2026 · strength 0.21
- Clint A. Stalnecker · 1 shared paper, 2026 · strength 0.21
- Harshabad Singh · 1 shared paper, 2026 · strength 0.19
- Courtney T.S. Kureshi · 1 shared paper, 2026 · strength 0.19
- Chong Zuo · 1 shared paper, 2026 · strength 0.19
- George Molina · 1 shared paper, 2026 · strength 0.19
- Thomas E. Clancy · 1 shared paper, 2026 · strength 0.19
- Qiang Li · 1 shared paper, 2026 · strength 0.19
- Douglas Adam Rubinson · 1 shared paper, 2026 · strength 0.19
- Sarah Slater · 1 shared paper, 2026 · strength 0.19
- Brian Matthew Wolpin · 1 shared paper, 2026 · strength 0.19
- Brandon M. Huffman · 1 shared paper, 2026 · strength 0.19
- Jonathan Andrew Nowak · 1 shared paper, 2026 · strength 0.19
- Kimberly J. Perez · 1 shared paper, 2026 · strength 0.19
- James M. Cleary · 1 shared paper, 2026 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.